Search research articles
Contact Us
Filters
Showing results (511-520 of 762) with videos related to
Page
of 77
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 18, 2016
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression
Kazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara, et al.
European Urology Oncology
|
April 30, 2024
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)
Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, et al.
Reproduction (Cambridge, England)
|
April 28, 2005
Estrous cycle characterisation and artificial insemination using frozen-thawed spermatozoa in the bottlenose dolphin (Tursiops truncatus)
T R Robeck, K J Steinman, M Yoshioka, et al.
Nanomaterials (Basel, Switzerland)
|
July 9, 2022
Formamidinium Lead Halide Perovskite Nanocomposite Scintillators
Isabel H B Braddock, Maya Al Sid Cheikh, Joydip Ghosh, et al.
Environmental Toxicology and Chemistry
|
June 9, 2022
Arbuscular Mycorrhizal Fungi and the Need for a Meaningful Regulatory Plant Protection Product Testing Strategy
Christopher J Sweeney, Melanie Bottoms, Sian Ellis, et al.
Neurology
|
April 1, 1988
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features
J A Kaye, C May, E Daly, et al.
Prostate Cancer and Prostatic Diseases
|
January 16, 2019
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
Edoardo Francini, Kathryn P Gray, Grace K Shaw, et al.
The Prostate
|
September 19, 2020
Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)
Lauren C Harshman, Victoria X Wang, Anis A Hamid, et al.
BJU International
|
January 26, 2016
Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence
Sarah M Rudman, Kathryn P Gray, Julie L Batista, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 28, 2015
(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer
Katherine A Zukotynski, Chun K Kim, Victor H Gerbaudo, et al.
Page
of 77
Search research articles
Search
Showing results (511-520 of 762) with videos related to
Sort By:
Page
of 77
Proceedings of the National Academy of Sciences of the United States of America
|
May 18, 2016
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression
Kazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara, et al.
European Urology Oncology
|
April 30, 2024
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)
Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, et al.
Reproduction (Cambridge, England)
|
April 28, 2005
Estrous cycle characterisation and artificial insemination using frozen-thawed spermatozoa in the bottlenose dolphin (Tursiops truncatus)
T R Robeck, K J Steinman, M Yoshioka, et al.
Nanomaterials (Basel, Switzerland)
|
July 9, 2022
Formamidinium Lead Halide Perovskite Nanocomposite Scintillators
Isabel H B Braddock, Maya Al Sid Cheikh, Joydip Ghosh, et al.
Environmental Toxicology and Chemistry
|
June 9, 2022
Arbuscular Mycorrhizal Fungi and the Need for a Meaningful Regulatory Plant Protection Product Testing Strategy
Christopher J Sweeney, Melanie Bottoms, Sian Ellis, et al.
Neurology
|
April 1, 1988
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features
J A Kaye, C May, E Daly, et al.
Prostate Cancer and Prostatic Diseases
|
January 16, 2019
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
Edoardo Francini, Kathryn P Gray, Grace K Shaw, et al.
The Prostate
|
September 19, 2020
Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)
Lauren C Harshman, Victoria X Wang, Anis A Hamid, et al.
BJU International
|
January 26, 2016
Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence
Sarah M Rudman, Kathryn P Gray, Julie L Batista, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 28, 2015
(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer
Katherine A Zukotynski, Chun K Kim, Victor H Gerbaudo, et al.
Page
of 77